Clinical Trials
17 trialsNCT06586255 2026-05-14
Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer
Abramson Cancer Center at Penn Medicine
Phase 1 Recruiting
NCT04902040 2026-04-30
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
Phase 1/2 Terminated
NCT04075305 2026-03-05
MOMENTUM
UMC Utrecht
Recruiting
NCT05879653 2025-08-29
Pembrolizumab and EV With Radiation Therapy for MIBC Patients (PEVRAD)
Kyoto University Hospital
Phase 2 Recruiting
NCT07053735 2025-07-08
An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer
Peking University First Hospital
Phase 1 Not yet recruiting
NCT02662062 2025-01-27
PCR-MIB
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2 Completed
NCT05397262 2024-05-09
HyBla_RCT
University of Erlangen-Nürnberg Medical School
Phase NA Recruiting
NCT03617913 2023-01-06
Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer
Mayo Clinic
Phase 2 Completed
NCT05082818 2022-06-14
Outcome of Treating Bladder Cancer in Sohag University Hospital
Sohag University
Completed
NCT00006111 2021-02-21
Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract
UNICANCER
Phase 2 Completed
NCT00867347 2019-01-04
Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder Cancer
Institute of Cancer Research, United Kingdom
Phase 3 Completed
NCT03150836 2017-10-19
Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer
University of California, San Francisco
Phase 2 Withdrawn
NCT01142102 2017-01-24
BOLART
Trans Tasman Radiation Oncology Group
Phase NA Completed
NCT00003704 2016-07-06
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Alliance for Clinical Trials in Oncology
Phase 1 Completed
NCT00556621 2015-07-30
GEMCIRAV
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 1/2 Completed
NCT00544609 2014-10-02
SOGUG-07-01
Spanish Oncology Genito-Urinary Group
Phase 1 Completed
NCT00002949 2013-09-05
Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis
University of Chicago
Phase 1 Completed